Ella Evron
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 13
- Oncology 14
- HER2/EGFR in Cancer Research 4
- Cancer-related Molecular Pathways 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Saraswati V. Sukumar (13 shared papers)Jeffrey R. Marks (4 shared papers)Christopher B. Umbricht (4 shared papers)Venu Raman (3 shared papers)Anne T Ferguson (2 shared papers)Dorian Korz (3 shared papers)Edward W. Gabrielson (2 shared papers)Elizabeth M. Jaffee (1 shared paper)
- Journals
- Annals of Oncology (5 papers)Oncogene (3 papers)npj Breast Cancer (3 papers)Cancers (3 papers)The Lancet (2 papers)
- Partner nations
- IsraelUnited StatesSwitzerland
In The Last Decade
Ella Evron
60 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 102
- Cancer Research 675
- Oncology 696
- Molecular Biology 1.6k
- Neurology 142
- Otorhinolaryngology 82
Countries citing papers authored by Ella Evron
This map shows the geographic impact of Ella Evron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella Evron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella Evron more than expected).
Fields of papers citing papers by Ella Evron
This network shows the impact of papers produced by Ella Evron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella Evron. The network helps show where Ella Evron may publish in the future.
Co-authors
The 25 scholars most cited alongside Ella Evron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 421 | |
| 2 | 2000 | 393 | |
| 3 | 2003 | 388 | |
| 4 | 2001 | 295 | |
| 5 | 2001 | 261 | |
| 6 | 2003 | 218 | |
| 7 | Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. | 2001 | 186 |
| 8 | Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. | 2001 | 184 |
| 9 | 1998 | 157 | |
| 10 | Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors. | 1998 | 142 |
| 11 | 1998 | 110 | |
| 12 | 2011 | 91 | |
| 13 | 2019 | 91 | |
| 14 | CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression. | 2001 | 77 |
| 15 | 2016 | 65 | |
| 16 | 2021 | 63 | |
| 17 | 2017 | 62 | |
| 18 | 2018 | 57 | |
| 19 | 2015 | 56 | |
| 20 | 2012 | 50 |
About Ella Evron
Ella Evron is a scholar working on Cancer Research, Oncology, Genetics, Molecular Biology and Pathology and Forensic Medicine, having authored 60 papers that have together received 3.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Epigenetics and DNA Methylation (12 papers), BRCA gene mutations in cancer (9 papers), HER2/EGFR in Cancer Research (4 papers), Cancer-related Molecular Pathways (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Cancer Research (675 citations), Oncology (696 citations), Molecular Biology (1.6k citations), Neurology (142 citations) and Otorhinolaryngology (82 citations). Ella Evron has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Saraswati V. Sukumar, Jeffrey R. Marks, Christopher B. Umbricht, Venu Raman, Anne T Ferguson, Dorian Korz, Edward W. Gabrielson, Elizabeth M. Jaffee, Ward F. Odenwald and David Reisman. Their work appears in journals such as Annals of Oncology, Oncogene, npj Breast Cancer, Cancers and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.